Nothing said here yet.
to join the conversation.
| Li David HPresident & CEO | Sell | 92 | $6.9K | Tue, Aug 18 |
| Li David HPresident & CEO | Sell | 5,000 | $379.1K | Mon, Aug 17 |
| Li David HPresident & CEO | Sell | 5,000 | $378.6K | Fri, Aug 14 |
Ingevity's Q2 adjusted EBITDA rose to $115 million, driven by favorable pricing, product mix and volumes, prompting higher 2026 earnings guidance.
NGVT's portfolio reshaping, acquisitions and strong cash flow support growth, while APT weakness and macro risks cloud the outlook.
NGVT's shares rally as portfolio optimization, capacity investments and debt reduction boost confidence in long-term growth prospects.
Ingevity (NYSE:NGVT) is nearing completion of a strategic portfolio transformation that has narrowed its focus to its Performance Materials and Pavement Technologies businesses, President and Chief Executive Officer David Li said during a Water Tower Research conference session.
Opportunities include contaminant-specific media, water and air purification, sustainable sourcing, regeneration, AI optimization, and resilient regional supply chains.Dublin, Sept.
Ingevity (NGVT) is back on investor calendars ahead of its appearance at the Water Tower Research Virtual Insights Conference on September 23, 2026, which is drawing attention to the stock’s recent performance profile.
Ingevity has delivered a solid multi year run in its share price, which naturally raises a question for anyone looking at the stock today.
Here is how Ingevity (NGVT) and Solstice Advanced Materials (SOLS) have performed compared to their sector so far this year.
NGVT's 19.2% YTD rally is backed by portfolio optimization, stronger hybrid demand, pricing gains and higher margins, fueling earnings growth.